Issue link: https://www.e-digitaleditions.com/i/1510011
STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Devices Provides excellent holding strength and can be used to close high-tension areas, such as fascia 1-2 © 2023 Ethicon US, LLC. All Rights Reserved. 256711-230820 References: 1. 100326296: Time Zero Tissue Holding - Competitive Claims Comparisons for STRATAFIX Knotless Tissue Control Devices vs Various Products. 2015. Ethicon, Inc. 2. Ethicon study AST-2013-0056 Performance Testing of STRATAFIX Symmetric PDS Size2-0 suture device for Tissue Holding Strength with Multiple Incision Defects to Measure Gapping. Ethicon, Inc. 3. Ming X, Rothenburger S, Nichols MM. In vivo and in vitro antibacterial efficacy of PDS Plus (polidioxanone with triclosan) suture. Surg Infect (Larchmt). 2008;9(4):451457. 4. Ming X, Rothenburger S, Yang D. In vitro antibacterial efficacy of Monocryl Plus Antibacterial Suture (poligelcaprone 25 with triclosan). Surg Infect (Larchmt).2007;8(2):201-207. **In an ex vivo model.†Superior to VICRYL and PDS® Plus Antibacterial (polydioxanone) Suture in fascia. Superior to V-Loc in subcutaneous tissue Symmetric Fixation tab anchors the device without the need for tying a knot Intact core and geometrically patterned anchors deliver strength and security with every pass Pressed symmetrical anchors maintain the core of the device Superior tissue- holding strength compared to interrupted technique with Coated VICRYL ® (polyglactin 910) Suture, continuous technique with PDS ® II (polydioxanone) Suture, and V-Loc™ 180 Wound Closure Device 1 **† STRATAFIX Symmetric PDS Plus Device offers Plus Antibacterial Technology to address a known risk factor for surgical site infection (SSI) 3-4*‡ Triclosan has in vitro activity that inhibits bacterial colonization of the suture. For illustration purposes only. ‡PDS Plus Suture and MONOCRYL Plus Suture only.